Small molecules (LC-MS/MS)
Centre of Excellence for Protein LC-MS
LGC’s Cambridge, Fordham facility is home to our Centre of Excellence for Protein LC-MS. Supported by the latest mass spectrometry technologies, we have developed in-depth expertise in this key area of analytical science with successful contributions to biopharmaceutical research.
Small molecule bioanalysis
With a focused strategic science team, and one of the largest purpose-built bioanalytical facilities in Europe, we continue to pioneer new method development techniques, such as small molecule biomarkers by LC-MS/MS, and apply novel technologies to help answer your analytical challenges.
Small molecule drugs
We provide small molecule drugs and biomarker analysis for pharmacokinetic (PK) and pharmacodynamics (PD) determinations from discovery support through to regulated GLP preclinical and GCP clinical studies.
Our flexible services include:
- Comprehensive feasibility
- Method establishment
- Development and transfer capabilities
- Validation and sample analysis
- Pharmacokinetic data analysis using validated software systems (e.g. WinNonlin,)
- Logistical support for clinical sample management including sample collection kit production
Working with you to meet the shortest possible sample analysis timelines, we are committed to providing data of the highest quality, using robust bioanalytical methods. We provide a single point of contact and regular project updates with the assurance of quality and accuracy from the very best scientific team.